SouthJersey
Footballguy
Kige Ramsey has 100+ times more reach than Dr YoCharlie Harper said:They need to move on from Dr. Yo.
They need to aim higher.
Kige Ramsey has 100+ times more reach than Dr YoCharlie Harper said:They need to move on from Dr. Yo.
They need to aim higher.
Yo likes the clicks.Kige Ramsey has 100+ times more reach than Dr Yo
Definitely not shtick, Otis is scorned.Guys guys. Come on. Settle down. Tomorrow is the big day with the big news and the big data will be released and it’ll skyrocket!
Tomorrow. Tomorrow.
I love ya.
Tomorrow.
You’re always a day away.
Per the press release they're going to submit findings and data to FDA "later this week".Does anybody know if when submitted to the FDA the full dataset or findings for each endpoint is made public on the FDA website?
Still mindboggling to me that nobody is picking this up (more doctor buzz, media), unless they are waiting for the full data release to validate findings.
Yep I’m trying to figure out if we get to see it all (what’s submitted) or just only what cydy decides to showPer the press release they're going to submit findings and data to FDA "later this week".
OF COURSE they are.Per the press release they're going to submit findings and data to FDA "later this week".
This may be the thread with the most lame excuses of any thread in the forum.“we became aware of some political issues behind the scenes and addressed that with the editor.”
Does his paper matter to his peers?Patterson is confident his paper will be published soon. Says its in a final approval stage. Also said something political got in the way earlier that they will have to deal with behind closed doors.
Recently, we found that combinations with CCL5/CCR5 antagonist and the anti-PD-L1 antibody inhibited tumor growth and improved overall survival in mice models of PDAC.5Here, we first determined that cancer-FOXP3 mediated immune escape by recruiting regulatory T cells via upregulation of CCL5. We provided the rationale that cancer-FOXP3 could identify PDAC patients suited for combination of ICI and the chemokines/chemokine receptors inhibitor, in order to improve response. Interestingly, CCR5 and CXCR4 serve as the co-receptors for HIV-1 entry into T cells, and they have been used as popular targets for the development of new drugs. BL-8040, the peptide-based motixafortide, exhibits encouraging results in combination treatment. Meanwhile, the CCR5 antagonists, such as the small molecular reagents like maraviroc and the humanized monoclonal anti-CCR5 antibody leronlimab, have achieved the primary endpoints in phase 3 clinical studies on HIV, and therefore could be considered for therapeutic repurposing in PDAC.
Conspiracy theories are hot. The good Doc dropping those in can keep the dream alive.This may be the thread with the most lame excuses of any thread in the forum.
No matter what happens, you recommended this #### at .30. Anyone who bought in then has made insane returns.I got a shout out from Dr. Yo for my new idea for a new t-shirt: Day 3 was a magic day!
Come on. Are you not feeling loved? What did she say?I had my daughter break down the test results. But she probably not experienced enough to matter or post here.
I hope u have 100% profits at this point.I got a shout out from Dr. Yo for my new idea for a new t-shirt: Day 3 was a magic day!
You tell me what your SAE high profile guy with all the experience says. Then I will tell you what my said. Mine hasn't changed a lot, fyi.Come on. Are you not feeling loved? What did she say?
They should be a combo: SAE’s reduced, and statistically significant efficacy.BTW, why are we not talking about SAE's anymore?
And they still are, not sure where Golf Guy is coming from.They should be a combo: SAE’s reduced, and statistically significant efficacy.
Its a good sign but there is no scientific correlation. Out.They should be a combo: SAE’s reduced, and statistically significant efficacy.
Serious question. Are you hammered right now?I'm providing information but doing it the wrong way. Wife says I'm being confirational. Much thanks to @chet. I will pick up tomorrow.
Are you new here?Serious question. Are you hammered right now?
Have you completed 2 classes in organic chemistry? Have you been a CR1 and traveled around the US to sites starting drug studies? Did you ascend to a CR2 and get on more important drug studies? Did you become at CR 3 and then the lead on drug studies? While this happened you were not with one company but different because they were fighting for you to work there?And they still are, not sure where Golf Guy is coming from.
Say what now?I will tell you my daughter's professional advice. Who knows, you might as well ride it out. But if there was any ground breaking info, I hope she would have told me.
They haven't given enough data publicly to be truly scrutinized.
Then ask why.
Please read this in the morning after you come back to reality and see if what you are saying makes any sense to yourself.Have you completed 2 classes in organic chemistry? Have you been a CR1 and traveled around the US to sites starting drug studies? Did you ascend to a CR2 and get on more important drug studies? Did you become at CR 3 and then the lead on drug studies? While this happened you were not with one company but different because they were fighting for you to work there?
Forget that, you are right.